On November 28, 2000, Bio-Rad Labratories announced that its new instrument for measuring HbA1c levels, called Micromat II, was chosen for use in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. The ACCORD trial is aimed at reducing cardiovascular disease in people with type 2 diabetes. The test will be used to measure the patients HbA1c levels at 60 different test sites throughout the U.S. and Canada.
“We are pleased to be part of the NIH ACCORD study,” said John Hertia, director of Business and Technology Development at Bio-Rad in the press release.
Bio-Rad Laboratories of Hercules, California designed the portable instrument that allows an HbAIc to be measured in five minutes. For more information, call (800) 224-6723 or log onto their Web site at www.bio-rad.com.